Home / Publications / Novel recyclization of 3,4-dihydroisoquinolines as an efficient route to a new type of heteroarylated derivatives of β-arylethylamines

Novel recyclization of 3,4-dihydroisoquinolines as an efficient route to a new type of heteroarylated derivatives of β-arylethylamines

Vadim Sergeevich Sochnev 1
Vadim Sergeevich Sochnev
Anatolii Savel'evich Morkovnik 1
Anatolii Savel'evich Morkovnik
Alexander Aleksandrovich Zubenko 2
Alexander Aleksandrovich Zubenko
Lyudmila Nikolaevna Divaeva 1
Lyudmila Nikolaevna Divaeva
Tatyana N Gribanova 1
Tatyana N Gribanova
Leonid Nikolaevich Fetisov 2
Leonid Nikolaevich Fetisov
Viktorya Vladimirovna Chekrysheva 2
Viktorya Vladimirovna Chekrysheva
Kristina Nikolaevna Kononenko 2
Kristina Nikolaevna Kononenko
Marya Anatol'evna Bodryakova 2
Marya Anatol'evna Bodryakova
Alexander Ivanovich Klimenko 2
Alexander Ivanovich Klimenko
Gennadii Sergeevich Borodkin 1
Gennadii Sergeevich Borodkin
Igor Arnol'dovich Èstrin 4
Igor Arnol'dovich Èstrin
Published 2022-10-21
CommunicationVolume 32, Issue 6, 795-797
3
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Sochnev V. S. et al. Novel recyclization of 3,4-dihydroisoquinolines as an efficient route to a new type of heteroarylated derivatives of β-arylethylamines // Mendeleev Communications. 2022. Vol. 32. No. 6. pp. 795-797.
GOST all authors (up to 50) Copy
Sochnev V. S., Morkovnik A. S., Zubenko A. A., Divaeva L. N., Demidov O. P., Gribanova T. N., Fetisov L. N., Chekrysheva V. V., Kononenko K. N., Bodryakova M. A., Klimenko A. I., Borodkin G. S., Èstrin I. A. Novel recyclization of 3,4-dihydroisoquinolines as an efficient route to a new type of heteroarylated derivatives of β-arylethylamines // Mendeleev Communications. 2022. Vol. 32. No. 6. pp. 795-797.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2022.11.029
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.11.029
TI - Novel recyclization of 3,4-dihydroisoquinolines as an efficient route to a new type of heteroarylated derivatives of β-arylethylamines
T2 - Mendeleev Communications
AU - Sochnev, Vadim Sergeevich
AU - Morkovnik, Anatolii Savel'evich
AU - Zubenko, Alexander Aleksandrovich
AU - Divaeva, Lyudmila Nikolaevna
AU - Demidov, Oleg Petrovich
AU - Gribanova, Tatyana N
AU - Fetisov, Leonid Nikolaevich
AU - Chekrysheva, Viktorya Vladimirovna
AU - Kononenko, Kristina Nikolaevna
AU - Bodryakova, Marya Anatol'evna
AU - Klimenko, Alexander Ivanovich
AU - Borodkin, Gennadii Sergeevich
AU - Èstrin, Igor Arnol'dovich
PY - 2022
DA - 2022/10/21
PB - Mendeleev Communications
SP - 795-797
IS - 6
VL - 32
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Sochnev,
author = {Vadim Sergeevich Sochnev and Anatolii Savel'evich Morkovnik and Alexander Aleksandrovich Zubenko and Lyudmila Nikolaevna Divaeva and Oleg Petrovich Demidov and Tatyana N Gribanova and Leonid Nikolaevich Fetisov and Viktorya Vladimirovna Chekrysheva and Kristina Nikolaevna Kononenko and Marya Anatol'evna Bodryakova and Alexander Ivanovich Klimenko and Gennadii Sergeevich Borodkin and Igor Arnol'dovich Èstrin},
title = {Novel recyclization of 3,4-dihydroisoquinolines as an efficient route to a new type of heteroarylated derivatives of β-arylethylamines},
journal = {Mendeleev Communications},
year = {2022},
volume = {32},
publisher = {Mendeleev Communications},
month = {Oct},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.11.029},
number = {6},
pages = {795--797},
doi = {10.1016/j.mencom.2022.11.029}
}
MLA
Cite this
MLA Copy
Sochnev, Vadim Sergeevich, et al. “Novel recyclization of 3,4-dihydroisoquinolines as an efficient route to a new type of heteroarylated derivatives of β-arylethylamines.” Mendeleev Communications, vol. 32, no. 6, Oct. 2022, pp. 795-797. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2022.11.029.

Keywords

o-benzothienylarenes
o-thieno[2,3-b]pyridinyl- arenes
3,4-dihydroisoquinolines
heterocyclization
recyclization
β-arylethylamines

Abstract

A new recyclization of 3,4-dihydroisoquinolines is a convenient route to derivatives of new bbb-(o-benzothienylaryl)-and bbb-(o-thieno[2,3-b]pyridinylaryl)-containing ethylamines. These compounds look promising monoaminergic agents.

References

1.
(a) A. Rosas-Cruz, N. Salinas-Jazmín and M. A. Velasco-Velázquez, Technol. Cancer Res. Treat., 2021, 15330338211027913
3.
Cancer and the Dopamine D2Receptor: A Pharmacological Perspective
Weissenrieder J.S., Neighbors J.D., Mailman R.B., Hohl R.J.
Journal of Pharmacology and Experimental Therapeutics, 2019
5.
5-Hydroxytryptamine (5-HT) Receptor Ligands
Kitson S.
Current Pharmaceutical Design, 2007
6.
Signaling Pathways Linked to Serotonin-Induced Superoxide Anion Production: A Physiological Role for Mitochondria in Pulmonary Arteries
Genet N., Billaud M., Rossignol R., Dubois M., Gillibert-Duplantier J., Isakson B.E., Marthan R., Savineau J., Guibert C.
Frontiers in Physiology, 2017
8.
Zubenko A.A., Morkovnik A.S., Divaeva L.N., Demidov O.P., Kartsev V.G., Sochnev V.S., Klimenko A.I., Dobaeva N.M., Borodkin G.S., Bodryakov A.N., Bodryakova M.A., Fetisov L.N.
Mendeleev Communications, 2021
9.
Zubenko A.A., Morkovnik A.S., Divaeva L.N., Demidov O.P., Sochnev V.S., Borodkina I.G., Drobin Y.D., Spasov A.A.
Mendeleev Communications, 2020
10.
Zubenko A.A., Morkovnik A.S., Divaeva L.N., Sochnev V.S., Demidov O.P., Klimenko A.I., Fetisov L.N., Bodryakov A.N., Bodryakova M.A., Borodkin G.S.
Mendeleev Communications, 2022
11.
(d) A. A. Zubenko, A. S. Morkovnik, L. N. Divaeva, V. S. Sochnev, O. P. Demidov, A. N. Bodryakov, L. N. Fetisov, K. N. Kononenko, M. A. Bodryakova and A. I. Klimenko, Russ. J. Gen. Chem., 2021, 91, 792 (Zh. Obshch. Khim., 2021, 91, 703)
12.
Synthesis of racemic 1,2,3,4-tetrahydroisoquinolines and their resolution
Suna E., Trapencieris P.
Chemistry of Heterocyclic Compounds, 2000
14.
CrysAlisPro Software System, version 1.171.38.41, Rigaku Oxford Diffraction, Oxford, 2015.
15.
10.1016/j.mencom.2022.11.029_b0045
Sheldrick
Acta Crystallogr., 2015
16.
10.1016/j.mencom.2022.11.029_b0050
Sheldrick
Acta Crystallogr., 2015
17.
OLEX2: a complete structure solution, refinement and analysis program
Dolomanov O.V., Bourhis L.J., Gildea R.J., Howard J.A., Puschmann H.
Journal of Applied Crystallography, 2009
18.
Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases
Kułaga D., Drabczyk A.K., Satała G., Latacz G., Rózga K., Plażuk D., Jaśkowska J.
European Journal of Medicinal Chemistry, 2022